Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

laboratory biomarker analysis (2)

cediranib maleate (1)

cetuximab (1)

temsirolimus (1)

Study Documents

Intervention Type

drug (2)

other (2)

biological (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

stage iv nasopharyngeal keratinizing squamous cell carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed

Recurrent Hypopharyngeal Squamous Cell Carcinoma
+35 more

Cetuximab
+2 more

Scottsdale, Arizona
+23 more

Feb 23, 2017

Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous

Completed

Recurrent Hypopharyngeal Squamous Cell Carcinoma
+22 more

Cediranib Maleate
Laboratory Biomarker Analysis

Boston, Massachusetts

Massachusetts General Hospital Cancer Center

Apr 14, 2015